Home
About
Overview
Sharing Data
ORCID
Help
History (29)
Lateral Ventricles
Ornidazole
Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial.
Karoshi Death
Immunotherapy in Parkinson's disease: Current status and future directions.
See All 29 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Immunotherapy in Parkinson's disease: Current status and future directions.
Immunotherapy in Parkinson's disease: Current status and future directions. Neurobiol Dis. 2019 12; 132:104587.
View in:
PubMed
subject areas
Animals
Humans
Immunotherapy
Parkinson Disease
authors with profiles
Jeffrey Kordower